Tobias Freyberg Justesen has been employed at the Center for Surgical Science since April 2021. He graduated from medical school at the University of Copenhagen in January 2020 and then spend a year in Sønderborg working as a medical intern (KBU).
He has a great passion for the oncological field and the focus of his research is novel treatment modalities for metastatic pancreatic and colorectal cancer – patient groups with high unmet needs.
2021-: PhD student, CSS
2020-21: Medical intern (KBU) at Lægekompagniet Nordals, General Practice
2020-20: Medical intern (KBU) at the Dep. of Internal Medicine, Hospital Southern Jutland
2018-20: Junior Medical Advisor, Roche Pharmaceuticals, Denmark
2018-19: Research Scholar, Dep. of Orthopaedic Surgery, Gentofte Hospital
2016-17: Teacher in cardiovascular and respiratory physiology, SupKu
2020: Cand.med., University of Copenhagen
The Checkpoint study
Pancreatic cancer is one of the most lethal cancers, with high metastatic potential and strong chemoresistance, projected to becoming the second leading cause of cancer-related death by 2030. The only known curative treatment is surgical resection. However, 80% of patients present with a non-resectable disease at time of diagnosis.
The trial is a prospective phase 2 study in patients with metastatic pancreatic cancer investigating the efficacy, safety and immunological response of irreversible electroporation and immunotherapy (i.e. PD-1 inhibition).
A study of electroporation in combination with immunotherapy including patients with metastatic colorectal cancer is in the study design phase.
- Justesen T, Freyberg J, Schultz ANØ. Database selection and data gathering methods in systematic reviews of qualitative research regarding diabetes mellitus – an explorative study. BMC Med Res Methodol. 2021 Apr;21(1):94.
- Ralli M, Justesen T, Frevert SC, Schultz ANØ. Traumatic iatrogenic chylothorax after external electrical cardioversion. 9, Respirology case reports. 2021. p. e00695.
- Justesen T, Olsen JB, Hesselvig AB, Mørup-Petersen A, Odgaard A. Does intraoperative contamination during primary knee arthroplasty affect patient-reported outcomes for patients who are uninfected 1 year after surgery? A prospective cohort study of 714 patients. Acta Orthop. 2020 Dec;91(6):750–5.
LAST UPDATE: MAY 2021